A product of independent beta probabilities dose escalation design for dual-agent phase I trials

General classes of multiple binary regression models in dose finding problems for combination therapies

(2013) Mauro Gasparini   JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES C-APPLIED STATISTICS

Adaptive designs for dual-agent phase I dose-escalation studies

(2013) Jennifer A. Harrington et al.   Nature Reviews Clinical Oncology

A Generalized Continual Reassessment Method for Two-Agent Phase I Trials

(2013) Thomas M. Braun et al.   Statistics in Biopharmaceutical Research

Escalation strategies for combination therapy Phase I trials

(2012) Michael J. Sweeting et al.   PHARMACEUTICAL STATISTICS

Continual Reassessment Method for Partial Ordering

(2011) Nolan A. Wages et al.   BIOMETRICS

The treatment versus experimentation dilemma in dose finding studies

(2011) D. Azriel et al.   JOURNAL OF STATISTICAL PLANNING AND INFERENCE

A modified toxicity probability interval method for dose-finding trials

(2010) Yuan Ji et al.   Clinical Trials

A Bayesian dose-finding procedure for phase I clinical trials based only on the assumption of monotonicity

(2010) John Whitehead et al.   STATISTICS IN MEDICINE

A Hierarchical Bayesian Design for Phase I Trials of Novel Combinations of Cancer Therapeutic Agents

(2009) Thomas M. Braun et al.   BIOMETRICS

A two-stage algorithm for designing phase I cancer clinical trials for two new molecular entities

(2009) Zheng Su   Contemporary Clinical Trials

Bayesian dose finding in oncology for drug combinations by copula regression

(2009) Guosheng Yin et al.   JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES C-APPLIED STATISTICS

A Latent Contingency Table Approach to Dose Finding for Combinations of Two Agents

(2008) Guosheng Yin et al.   BIOMETRICS

Critical aspects of the Bayesian approach to phase I cancer trials

(2008) Beat Neuenschwander et al.   STATISTICS IN MEDICINE